Cardiac Resynchronization Therapy in Patients with Ebstein's Anomaly

Int Heart J. 2017 Oct 21;58(5):816-819. doi: 10.1536/ihj.16-580. Epub 2017 Sep 30.

Abstract

Ebstein's anomaly is a rare congenital heart disease characterized by apical displacement of the septal and posterior tricuspid valve leaflets. It is often complicated with left ventricular (LV) dysfunction as well as right-sided abnormalities. On the other hand, in the presence of LV dysfunction, right ventricular pacing is likely to aggravate the diseased LV function, which is termed pacemaker-induced cardiomyopathy. Thus, deteriorating effects of RV pacing on cardiac function might be enhanced and result in pacemaker-induced cardiomyopathy in patients with Ebstein's anomaly, even if they have preserved LVEF. Cardiac resynchronization therapy (CRT) is effective for the treatment of pacemaker-induced cardiomyopathy, and we present the first case of effect of CRT on pacemaker-induced cardiomyopathy associated with Ebstein's anomaly.

Keywords: Pacemaker-induced cardiomyopathy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cardiac Pacing, Artificial / adverse effects*
  • Cardiac Pacing, Artificial / methods
  • Cephalosporins
  • Defibrillators, Implantable*
  • Ebstein Anomaly / therapy*
  • Echocardiography
  • Electrocardiography
  • Female
  • Heart Ventricles / diagnostic imaging
  • Heart Ventricles / physiopathology*
  • Humans
  • Stroke Volume / physiology
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Left / therapy*
  • Ventricular Function, Left / physiology*

Substances

  • Cephalosporins
  • MT 0703